INmune Bio

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell INmune Bio and other ETFs, options, and stocks.

About INMB

INmune Bio, Inc. is a clinical stage biotechnology company, which engages in developing new immunotherapies that reprogram the immune system to fight cancer and Alzheimer’s disease. Its product pipeline includes INKMUNE-Cancer, INB03-Cancer, XPRO1595-Alzheimer and TRD, and LIVNate.

CEO

Raymond J. Tesi

CEORaymond J. Tesi

Employees

Employees22

Headquarters

Boca Raton, Florida

HeadquartersBoca Raton, Florida

Founded

2015

Founded2015

Employees

Employees22

INMB Key Statistics

Market cap

62.87M

Market cap62.87M

Price-Earnings ratio

-1.21

Price-Earnings ratio-1.21

Dividend yield

—

Dividend yield—

Average volume

11.97M

Average volume11.97M

High today

$2.43

High today$2.43

Low today

$1.99

Low today$1.99

Open price

$2.06

Open price$2.06

Volume

5.93M

Volume5.93M

52 Week high

$11.64

52 Week high$11.64

52 Week low

$1.89

52 Week low$1.89

INMB News

TipRanks 2d

Inmune Bio Secures $18.9 Million in Stock Offering

Don’t Miss TipRanks’ Half-Year Sale Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights...

Analyst ratings

50%

of 6 ratings

Buy

33.3%

Hold

50%

Sell

16.7%

People also own

Based on the portfolios of people who own INMB. This list is generated using Robinhood data, and it’s not a recommendation.